- decreased leukocyte cell number / IMPC
- increased body weight / IMPC
- hyperactivity / IMPC
- abnormal behavior / IMPC
- thrombocytosis / IMPC
- increased hemoglobin content / IMPC
- decreased blood urea nitrogen level / IMPC
- decreased circulating bilirubin level / IMPC
- increased total body fat amount / IMPC
- decreased grip strength / IMPC
CBACa;129P2-Ankrd13aGt(RRH308)Byg/WtsiCnbc
Status | Available to order |
EMMA ID | EM:05014 |
International strain name | CBACa;129P2-Ankrd13aGt(RRH308)Byg/WtsiCnbc |
Alternative name | Ankrd13a genetrap |
Strain type | Gene-trap |
Allele/Transgene symbol | Ankrd13aGt(RRH308)Byg, |
Gene/Transgene symbol | Ankrd13a |
Information from provider
Provider | Karen Steel |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | A genetrap from BayGenomics in the Ankrd13a gene. |
Phenotypic information | Mild weight, skeletal, haematology and clinical chemistry anomalies in homozygotes (see Wellcome Trust Sanger Institute phenotyping data on web). |
Breeding history | Chimaeras from the 129P2 ES cells were mated with CBA/Ca and then the colony maintained by intercrossing. |
References | None available |
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Disease and phenotype information
IMPC phenotypes (allele matching)
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).